West Pharmaceutical Services, Inc. (WST) has become a focal point for investors due to several class action lawsuits related to securities fraud. Investors are being urged by prominent law firms to contact them for litigation and potential recovery of losses. Firms such as Kirby McInerney LLP, Levi & Korsinsky, The Gross Law Firm, and the Pomerantz Law Firm, are reminding WST investors of their rights and upcoming deadlines. Despite the controversy, West Pharmaceutical Services continues its business operations, announcing leadership changes, and declaring its first, third, and fourth quarter dividends for 2024, raising its fiscal year 2024 guidance. Furthermore, the company announces a landmark collaboration with Corning in Pharmaceutical Injectable Drug Delivery.
West Pharmaceutical Services WST News Analytics from Tue, 25 Jan 2022 08:00:00 GMT to Sat, 24 May 2025 18:30:00 GMT -
Rating +2
- Innovation -2
- Information +6
- Rumor -3
